New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases.

Authors:
Park J; Park IS; Kim JH; Ji JH; Park SJ and 4 more

Journal:
Therap Adv Gastroenterol

Publication Year: 2024

DOI:
10.1177/17562848241227029

PMCID:
PMC10822078

PMID:
38282956

Journal Information

Full Title: Therap Adv Gastroenterol

Abbreviation: Therap Adv Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2022R1G1A1006934). This study was also supported by a faculty research grant from Yonsei University College of Medicine (6-2021-0121)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025